Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights-Reference-Cited by-同舟云学术

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

Published:2012-04 Issue:8 Volume:81 Page:727-732
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Macdougall Iain C.,Roger Simon D.,de Francisco Angel,Goldsmith David J.A.,Schellekens Huub,Ebbers Hans,Jelkmann Wolfgang,London Gérard,Casadevall Nicole,Hörl Walter H.,Kemeny David M.,Pollock Carol

Publisher

Elsevier BV

Subject

Nephrology

Reference48 articles.

1. Epoetin-associated pure red cell aplasia: past, present, and future considerations;McKoy;Transfusion,2008

2. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin;Casadevall;N Engl J Med,2002

3. Pure red cell aplasia induced by erythropoiesis-stimulating agents;Pollock;Clin J Am Soc Nephrol,2008

4. A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia;Macdougall;N Engl J Med,2009

5. Pure red cell aplasia induced by only intravenous administration of recombinant human erythropoietin;Shimizu;Acta Haematol,2011

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-B*46:01:01:01 and HLA-DRB1*09:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia;Scientific Reports;2023-12-20

2. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges;Nature Reviews Drug Discovery;2023-12-20

3. A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab;Science Translational Medicine;2023-02

4. Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs;Journal of Pharmaceutical Sciences;2022-04

5. Precursor‐Targeted Immune‐Mediated Anemia and Pure Red Cell Aplasia in Dogs and Cats;Schalm's Veterinary Hematology;2022-03-04